[Myocardial injury and infarction is an overlooked complication after non-cardiac surgery]

Mikkel Holm Larsen1, Sarah Ekeløf, Ismail Gögenur

  • 1Kirurgisk Afdeling, Køge Sygehus, Lykkebækvej 1, 4600 Køge. m.hhlarsen@gmail.com.

Ugeskrift for Laeger
|June 24, 2015
PubMed

Insights

Millions of patients experience perioperative myocardial injury after non-cardiac surgery, leading to high mortality. This review clarifies the pathophysiology, diagnostics, and treatment of this common complication, including new risk stratification tools.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Perioperative Medicine

Background:

  • Non-cardiac surgery patients frequently develop perioperative myocardial injury or infarction.
  • This complication is linked to significant mortality.
  • Understanding pathophysiology and treatment remains challenging.

Purpose of the Study:

  • To review the prevalence, pathophysiology, diagnostics, risk stratification, and treatment of perioperative myocardial injury and infarction.
  • To highlight a newly developed risk stratification tool for identifying at-risk patients.

Main Methods:

  • Literature review focusing on perioperative myocardial injury and infarction.
  • Analysis of current diagnostic and treatment strategies.
  • Evaluation of a novel risk stratification tool.

Main Results:

  • Perioperative myocardial injury and infarction are common and deadly complications.
  • Pathophysiology is not fully understood, necessitating further research.
  • A new risk stratification tool aids in identifying high-risk individuals.

Conclusions:

  • Effective management requires understanding prevalence, pathophysiology, and diagnostics.
  • Risk stratification is crucial for early intervention.
  • Further research into treatment is essential to reduce mortality.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
435
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.7K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
478
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
603
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
326